Article Text

PDF
Inducing remission in inflammatory bowel disease
  • Relevant BNF section: 1.5

Abstract

Around 2-4 in 1,000 people in Northern Europe have ulcerative colitis or Crohn's disease. Both are chronic relapsing inflammatory disorders of the gastrointestinal tract and share several clinical features. However, they are largely distinct in their risk factors, their genetic, immunological, anatomical and histological features, and their response to medical and surgical therapy. Their treatment is usually considered in two phases: the induction of remission in an acute attack, and the long-term maintenance of remission. In 2001, we discussed maintenance treatment in adults.1 We now discuss the induction of remission, concentrating on newer therapeutic approaches.

Statistics from Altmetric.com

  • Relevant BNF section: 1.5

View Full Text

Footnotes

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.